Wenqun Xing

Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer

Shun Lü, Wei Zhang, Lin Wu et al. · JAMA · 2024 · 336 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study

Wenqun Xing, Lingdi Zhao, Baoxing Liu et al. · Frontiers in Immunology · 2021 · 72 citations · Full text

Medicine, Oncology, Surgery +16

The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target

D.T. Chen, Jia-Hao Pan, Y.H. Chen et al. · British Journal of Anaesthesia · 2018 · 63 citations · Full text

Medicine, Oncology, Pharmacology +12

A phase II, single-centre trial of neoadjuvant toripalimab plus chemotherapy in locally advanced esophageal squamous cell carcinoma

Wenqun Xing, Lingdi Zhao, Xiaomin Fu et al. · Journal of Thoracic Disease · 2020 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules

Wenqun Xing, Haibo Sun, Chi Yan et al. · BMC Cancer · 2021 · 41 citations · Full text

Medicine, Oncology, Radiology +17